About XMedius
XMedius is a company based in Montreal (Canada) founded in 1993, and was acquired by OpenText in March 2020. Renal disease medications and dialysis products are manufactured. Its website xmedius.com draws about 82 thousand monthly visits. Its legal entity is Open Text Corporation.
Company details
XMedius was founded in 1993 and is based in Montreal, Canada. Operations are centered in the pharmaceutical sector, where medications for renal disease and dialysis products are produced. A portfolio including alpha-ketoanalogue tablets and sevelamer carbonate tablets is maintained. Products undergo rigorous quality checks to comply with industry standards. The focus remains on renal disease treatment within the healthcare domain.
Apps and channels of XMedius
its YouTube channel OpenText has 12.4K subscribers and 30 videos.
Videos from XMedius
The most watched videos on XMedius's YouTube channel, OpenText (12.4K subscribers). Click a video to play it here.
More on OpenText.
Investors in XMedius
XMedius has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include OpenText and StoneCalibre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cloud-based enterprise information management and GRC solutions are provided. | 1991 | opentext.com | Waterloo, Canada | |
StoneCalibre is recognized as an international private investment firm. | 2012 | stonecalibre.com | Los Angeles, United States |
Investor details for XMedius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of XMedius
3 dated milestones of XMedius across 27 years, from founding to its latest funding, stage changes and deals.
- Founded XMedius is founded.
- Exit Acquired by StoneCalibre.
- Exit Acquired by OpenText.
Web traffic of XMedius
The website of XMedius (xmedius.com) receives about 82.2K visits a month.
- Monthly visits82.2K
▲ 99.2% vs previous month
Websites whose visitors overlap most with XMedius. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
satorisolutions.com | satorisolutions.com | 100% | – | ||
| etherfax.net | 91% | 4.6K | #3,951,443 | View details | |
| syscomservices.com | 87% | View details | |||
| bizcomweb.com | 87% | 680.7K | #11,842,559 | View details | |
| ingeniumsw.com | 87% | #12,720,006 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for XMedius
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about XMedius
XMedius was founded in 1993.
XMedius is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
XMedius was founded in 1993 and is based in Montreal, Canada. Operations are centered in the pharmaceutical sector, where medications for renal disease and dialysis products are produced. A portfolio including alpha-ketoanalogue tablets and sevelamer carbonate tablets is maintained. Products undergo rigorous quality checks to comply with industry standards. The focus remains on renal disease treatment within the healthcare domain.
XMedius has 2 investors. Key investors include OpenText, and StoneCalibre.
XMedius operates through Open Text Corporation.
Yes. XMedius was acquired by OpenText in March 2020.